Bleeding treatments: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
#pRBCs | #pRBCs | ||
#DDAVP 0.3mg/kg subQ or IV (max 20mg) | #DDAVP 0.3mg/kg subQ or IV (max 20mg) | ||
#Platelets | #[[Platelet transfusion|Platelets]] | ||
#FFP | #[[Fresh frozen plasma|FFP]] | ||
# | #[[Cryoprecipitate]] | ||
#Vitamin K (10mg SQ/IM) | #[[Vitamin_K|Vitamin K (10mg SQ/IM)]] | ||
#Protamine (Heparin) | #[[Unfractionated_heparin_reversal|Protamine (Heparin reversal)]] | ||
#Estrogen (Uterine, renal) | #Estrogen (Uterine, renal) | ||
#PPI/Pepcid/Octreotide (GI) | #PPI/Pepcid/Octreotide (GI) |
Revision as of 15:15, 10 August 2015
Treatments
- pRBCs
- DDAVP 0.3mg/kg subQ or IV (max 20mg)
- Platelets
- FFP
- Cryoprecipitate
- Vitamin K (10mg SQ/IM)
- Protamine (Heparin reversal)
- Estrogen (Uterine, renal)
- PPI/Pepcid/Octreotide (GI)
- Quick Clot (Topical)
See Also
Source
- Tintinalli